BackGwo Xi Stem Cell Applied Technology , Ltd Overview
Gwo Xi Stem Cell Applied Technology Co. , Ltd

Gwo Xi Stem Cell Applied Technology , Ltd Return on Equity

Gwo Xi Stem Cell Applied Technology , Ltd (6704.TWO) has a ROE of -22.65%, below the Healthcare sector average of 13.1%.

Get informed when a big investor buys or sells

+ Follow

ROE

-22.65%

Return on Equity

-22.65%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Gwo Xi Stem Cell Applied Technology , Ltd (6704.TWO) FAQ

Gwo Xi Stem Cell Applied Technology , Ltd (6704.TWO) currently reports a ROE of -22.65%. That is below the Healthcare sector average of 13.1%. Use the charts on this page to explore Gwo Xi Stem Cell Applied Technology , Ltd's ROE history and peer comparisons.

Gwo Xi Stem Cell Applied Technology , Ltd's ROE of -22.65% is lower than the Healthcare sector average of 13.1%. That is roughly 272.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Gwo Xi Stem Cell Applied Technology , Ltd's current -22.65% should be judged against Healthcare norms (sector average: 13.1%) and against 6704.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -22.65%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.1%. From there, open related valuation or income-statement pages for Gwo Xi Stem Cell Applied Technology , Ltd, and consider following 6704.TWO for alerts when major investors trade the stock.

Gwo Xi Stem Cell Applied Technology , Ltd is classified in the Healthcare sector. On ROE, it currently shows -22.65% versus a sector average near 13.1%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6704.TWO with unrelated industries.